Literature DB >> 31789949

Vitamin D-related immunomodulation in patients with liver cirrhosis.

Christos Triantos1, Maria Kalafateli1, Ioanna Aggeletopoulou1,2, Georgia Diamantopoulou1, Panagiota I Spantidea2, Marina Michalaki3, Georgia Vourli4, Christos Konstantakis1, Stelios F Assimakopoulos5, Spilios Manolakopoulos6, Charalambos Gogos5, Venetsana Kyriazopoulou3, Athanasia Mouzaki2, Konstantinos Thomopoulos1.   

Abstract

OBJECTIVE(S): Increasing evidence indicates that vitamin D status is linked to severity of liver cirrhosis and patients' survival. However, the potential role of vitamin D-related immunomodulation in hepatic decompensation and patients' mortality in relation to vitamin D deficiency remains unknown. The aim of the current study is to evaluate the association between vitamin D status and vitamin D binding protein (VDBP) levels with serum cytokine and lipopolysaccharide binding protein (LBP) and to examine their role on disease severity and cirrhotics' mortality.
METHODS: One hundred consecutive Caucasian patients with liver cirrhosis were enrolled in the study. 25(OH)D, VDBP, and LBP concentrations were assessed by ELISA. Cytokine tumor necrosis factor-a (TNF-a), interleukin 6 (IL-6), IL-1β, IL-8, IL-10, and IL-12 levels were determined by Cytometric Bead Array.
RESULTS: 25(OH)D levels were inversely correlated with CP score, MELD, IL-6, and CP stage and VDBP levels with CP score, MELD, IL-6, IL-8, LBP, and CP stage. Cirrhotics with 25(OH)D deficiency and severe deficiency had significantly higher CP score, increased IL-6 levels and lower VDBP levels. In the multivariate analysis, the independent prognostic factors associated with patients' survival were CP stage B [hazard ratio = 6.75; 95% confidence interval (CI) 1.32, 34.43; P = 0.022], CP stage C (hazard ratio = 7.39; 95% CI 1.41, 38.81; P = 0.018), the presence of hepatocellular carcinoma (hazard ratio = 4.50; 95% CI 1.54, 13.13; P = 0.006) and 25(OH)D levels (hazard ratio = 0.87; 95% CI 0.80, 0.95; P = 0.002).
CONCLUSION: The results show that vitamin D status and VDBP levels are associated with liver cirrhosis severity and patients' mortality, possibly through a proinflammatory immune response.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31789949     DOI: 10.1097/MEG.0000000000001597

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  8 in total

1.  Effect of Perioperative Interleukin-6 and Tumor Necrosis Factor-α on Long-Term Outcomes in Locally Advanced Gastric Cancer: Results from the CLASS-01 Trial.

Authors:  Zhenzhan Zhang; Binshu Weng; Yaopeng Qiu; Hao Feng; Renyi Zhang; Jiachen Zhang; Yanfeng Hu; Jiang Yu; Guoxin Li; Hao Liu
Journal:  J Immunol Res       Date:  2022-07-08       Impact factor: 4.493

2.  The effect of comfort nursing on liver function and nursing satisfaction of patients with liver cirrhosis.

Authors:  Mei Cui; Meihong Sun; Lu Bu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  The effect of vitamin D supplementation on the progression of fibrosis in patients with chronic liver disease: A protocol for a systematic review and meta-analysis.

Authors:  Tiantian Chen; Xiaohong Zuo; Shengju Wang; Penglong Yu; Jie Yuan; Shujun Wei; Jiayi Chen; Yue Sun; Yongxiang Gao; Xueping Li
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

4.  Indoleamine 2,3-dioxygenase 1 limits hepatic inflammatory cells recruitment and promotes bile duct ligation-induced liver fibrosis.

Authors:  Chan Mo; Shuwen Xie; Bin Liu; Weichao Zhong; Ting Zeng; Sha Huang; Yuqi Lai; Guanghui Deng; Chuying Zhou; Weixin Yan; Yuyao Chen; Shaohui Huang; Lei Gao; Zhiping Lv
Journal:  Cell Death Dis       Date:  2021-01-07       Impact factor: 8.469

Review 5.  The Role of Vitamin Deficiency in Liver Disease: To Supplement or Not Supplement?

Authors:  Anna Licata; Maddalena Zerbo; Silvia Como; Marcella Cammilleri; Maurizio Soresi; Giuseppe Montalto; Lydia Giannitrapani
Journal:  Nutrients       Date:  2021-11-10       Impact factor: 5.717

6.  The role of vitamin D receptor polymorphisms in the course of chronic hepatitis C infection.

Authors:  Efthymios P Tsounis; Evanthia Tourkochristou; Aggeliki Sapsani; Ioanna Aggeletopoulou; Theoni Lourida; Κonstantinos Ζisimopoulos; Theodoros Tzikopoulos; Georgia Diamantopoulou; Aggeliki Tsintoni; Konstantinos Thomopoulos; Athanasia Mouzaki; Christos Triantos
Journal:  Ann Gastroenterol       Date:  2022-02-14

Review 7.  Vitamin D-VDR Novel Anti-Inflammatory Molecules-New Insights into Their Effects on Liver Diseases.

Authors:  Ioanna Aggeletopoulou; Konstantinos Thomopoulos; Athanasia Mouzaki; Christos Triantos
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

8.  Potential roles of vitamin D binding protein in attenuating liver injury in sepsis.

Authors:  Kun Xiao; Du-Chao Zhang; Ye Hu; Li-Cheng Song; Jian-Qiao Xu; Wan-Xue He; Pan Pan; Yu-Wei Wang; Li-Xin Xie
Journal:  Mil Med Res       Date:  2022-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.